Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(2 sites)
United States
College of Public Health and Health Professions, University of Florida, Gainesville, Florida University of Florida, Gainesville, Florida